Systemic and renal growth hormone–IGF1 axis involvement in a mouse model of type 2 diabetesYael Segev(Ben-Gurion University of the Negev), Daniel Landau(Tel Aviv University)DiabetologiaApril 19, 200710.1007/s00125-007-0663-7Cited by 20SaveCiteExport RISWatch citationsRelated PapersThe hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia|PLoS ONE|2018|41